183 related articles for article (PubMed ID: 36054506)
1. Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer.
Li Y; Wang Y; Zhou W; Chen Y; Lou Y; Qian F; Lu J; Jiang H; Xiang B; Zhang Y; Han B; Zhang W
Thorac Cancer; 2022 Oct; 13(19):2711-2722. PubMed ID: 36054506
[TBL] [Abstract][Full Text] [Related]
2. Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
Wang Y; Chen Y; Yang Z; Qian F; Hu M; Lu J; Zhang Y; Zhang W; Wang K; Han B
Ann Surg Oncol; 2022 Sep; 29(9):5666-5678. PubMed ID: 35543906
[TBL] [Abstract][Full Text] [Related]
3. Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung.
Wang Y; Qian F; Chen Y; Yang Z; Hu M; Lu J; Zhang Y; Zhang W; Cheng L; Han B
Front Oncol; 2021; 11():714549. PubMed ID: 34631540
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study.
Lei Y; Feng H; Qiang H; Shang Z; Chang Q; Qian J; Zhang Y; Zhong R; Fan X; Chu T
Lung Cancer; 2020 Aug; 146():244-251. PubMed ID: 32592985
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer (SCLC) after surgical resection.
Guo Y; Yang L; Liu L; Wei J; Teng F; Zhang J; Zhu Y; Xing P; Li J
Thorac Cancer; 2020 Oct; 11(10):2782-2792. PubMed ID: 32779385
[TBL] [Abstract][Full Text] [Related]
6. Resected Pure Small Cell Lung Carcinomas and Combined Small Cell Lung Carcinomas: Histopathology Features, Imaging Features, and Prognoses.
Woo JH; Kim MY; Lee KS; Jeong DY; Chung MJ; Han J; Shim YM
AJR Am J Roentgenol; 2019 Apr; 212(4):773-781. PubMed ID: 30673331
[TBL] [Abstract][Full Text] [Related]
7. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W
BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979
[TBL] [Abstract][Full Text] [Related]
8. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung carcinoma.
Zhu Y; Li S; Wang H; Chi K; Ren W; Huang X; Zhuo M; Lin D
Hum Pathol; 2023 Nov; 141():118-129. PubMed ID: 37586462
[TBL] [Abstract][Full Text] [Related]
10. YAP1 protein expression has variant prognostic significance in small cell lung cancer (SCLC) stratified by histological subtypes.
Wang X; Guo Y; Liu L; Wei J; Zhang J; Xie T; Dong J; Li J; Xing P; Yang L
Lung Cancer; 2021 Oct; 160():166-174. PubMed ID: 34364705
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer.
Jiang R; Wang X; Li K
Oncotarget; 2016 May; 7(18):26823-36. PubMed ID: 27072585
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker.
Yokouchi H; Nishihara H; Harada T; Ishida T; Yamazaki S; Kikuchi H; Oizumi S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Takamura K; Kojima T; Higuchi M; Honjo O; Minami Y; Watanabe N; Goto A; Suzuki H; Dosaka-Akita H; Isobe H; Nishimura M; Munakata M
Oncotarget; 2017 Jun; 8(24):39711-39726. PubMed ID: 28055980
[TBL] [Abstract][Full Text] [Related]
13. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic lymphoma kinase expression in small-cell lung cancer.
Kondoh C; Horio Y; Hayashi Y; Ebi H; Hida T; Hasegawa Y; Yatabe Y
Histopathology; 2019 Jul; 75(1):20-28. PubMed ID: 30790327
[TBL] [Abstract][Full Text] [Related]
15. Selective application of neuroendocrine markers in the diagnosis and treatment of small cell lung cancer.
Du J; Li Y; Wang L; Zhou Y; Shen Y; Xu F; Chen Y
Clin Chim Acta; 2020 Oct; 509():295-303. PubMed ID: 32592711
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of serum tumor markers CEA, CYFRA21-1, SCCAg, NSE and ProGRP for lung cancers of different pathological types].
Gao J; Zhang L; Peng K; Sun H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jun; 42(6):886-891. PubMed ID: 35790439
[TBL] [Abstract][Full Text] [Related]
17. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer.
Wang L; Wang D; Zheng G; Yang Y; Du L; Dong Z; Zhang X; Wang C
Int J Biol Markers; 2016 Feb; 31(1):e80-7. PubMed ID: 26560853
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract][Full Text] [Related]
20. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
Jiang ZF; Wang M; Xu JL
Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]